Shift in monocyte apoptosis with increasing viral load and change in apoptosis-related ISG/Bcl2 family gene expression in chronically HIV-1-infected subjects

Journal of Virology

Volumn 89, Issue 1, 2015, Pages 799-810

  Patro, Sean C ^a,b   Pal, Sharmistha ^a   Bi, Yingtao ^a   Lynn, Kenneth ^c   Mounzer, Karam C ^d   Kostman, Jay R ^c   Davuluri, Ramana V ^a   Montaner, Luis J ^a  

^a WISTAR INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c PENN PRESBYTERIAN MEDICAL CENTER   (United States)

^d Philadelphia Fight   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPHYCOCYANIN; CASPASE 3; CD14 ANTIGEN; CD16 ANTIGEN; CD163 ANTIGEN; CYTOCHROME C; INTERFERON; INTERFERON ALPHA INDUCIBLE PROTEIN 27; INTERFERON ALPHA INDUCIBLE PROTEIN 6; INTERFERON INDUCED TRANSMEMBRANE PROTEIN 2; INTERFERON REGULATORY FACTOR; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL W; PROTEIN MCL 1; PROTEIN MDM2; PROTEIN P53; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

ADULT; APOPTOSIS; ARTICLE; CD4 LYMPHOCYTE COUNT; CELL ACTIVATION; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNOPHENOTYPING; INFECTION; INNATE IMMUNITY; MACROPHAGE ACTIVATION; MALE; MONOCYTE; OXIDATIVE STRESS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIREMIA; VIRUS LOAD; BIOSYNTHESIS; CHRONIC DISEASE; GENE EXPRESSION PROFILING; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MIDDLE AGED; PHYSIOLOGY; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ADULT; AGED, 80 AND OVER; APOPTOSIS; CHRONIC DISEASE; FEMALE; GENE EXPRESSION PROFILING; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; MONOCYTES; PROTO-ONCOGENE PROTEINS C-BCL-2; RETINOBLASTOMA PROTEIN; VIRAL LOAD; YOUNG ADULT;

EID: 84919429679     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02382-14     Document Type: Article

References (76)

1. Alkhatib G. 2009. The biology of CCR5 and CXCR4. Curr Opin HIV AIDS 4:96-103. http://dx.doi.org/10.1097/COH.0b013e328324bbec.
2. Guadalupe M, Reay E, Sankaran S, Prindiville T, Flamm J, McNeil A, Dandekar S. 2003. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J Virol 77:11708-11717. http://dx.doi.org/10.1128/JVI.77.21.11708-11717.2003.
3. Badley AD, Pilon AA, Landay A, Lynch DH. 2000. Mechanisms of HIV-associated lymphocyte apoptosis. Blood 96:2951-2964.
4. Yue FY, Kovacs CM, Dimayuga RC, Gu XX, Parks P, Kaul R, Ostrowski MA. 2005. Preferential apoptosis of HIV-1-specific CD4+ T cells. J Immunol 174:2196-2204. http://dx.doi.org/10.4049/jimmunol.174.4.2196.
5. Gekonge B, Giri MS, Kossenkov AV, Nebozyhn M, Yousef M, Mounzer K, Showe L, Montaner LJ. 2012. Constitutive gene expression in monocytes from chronic HIV-1 infection overlaps with acute Toll-like receptor induced monocyte activation profiles. PLoS One 7:e41153. http://dx.doi.org/10.1371/journal.pone.0041153.
6. Rempel H, Sun B, Calosing C, Abadjian L, Monto A, Pulliam L. 2013. Monocyte activation in HIV/HCV coinfection correlates with cognitive impairment. PLoS One 8:e55776. http://dx.doi.org/10.1371/journal.pone.0055776.
7. Pulliam L, Rempel H, Sun B, Abadjian L, Calosing C, Meyerhoff DJ. 2011. A peripheral monocyte interferon phenotype in HIV infection correlates with a decrease in MRS metabolite concentrations. AIDS 25:1721-1726. http://dx.doi.org/10.1097/QAD.0b013e328349f022.
8. Rempel H, Sun B, Calosing C, Pillai SK, Pulliam L. 2010. Interferon-α drives monocyte gene expression in chronic unsuppressed HIV-1 infection. AIDS 24: 1415-1423. http://dx.doi.org/10.1097/QAD.0b013e32833ac623.
9. Pulliam L, Sun B, Rempel H. 2004. Invasive chronic inflammatory monocyte phenotype in subjects with high HIV-1 viral load. J Neuroimmunol 157:93-98. http://dx.doi.org/10.1016/j.jneuroim.2004.08.039.
10. Pulliam L, Gascon R, Stubblebine M, McGuire D, McGrath M. 1997. Unique monocyte subset in patients with AIDS dementia. Lancet 349: 692-695. http://dx.doi.org/10.1016/S0140-6736(96)10178-1.
11. Ellery PJ, Tippett E, Chiu YL, Paukovics G, Cameron PU, Solomon A, Lewin SR, Gorry PR, Jaworowski A, Greene WC, Sonza S, Crowe SM. 2007. The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo. J Immunol 178:6581-6589. http://dx.doi.org/10.4049/jimmunol.178.10.6581.
12. Williams K, Burdo TH. 2012. Monocyte mobilization, activation markers, and unique macrophage populations in the brain: observations from SIV infected monkeys are informative with regard to pathogenic mechanisms of HIV infection in humans. J Neuroimmune Pharmacol 7:363-371. http://dx.doi.org/10.1007/s11481-011-9330-3.
13. Sandler NG, Wand H, Roque A, Law M, Nason MC, Nixon DE, Pedersen C, Ruxrungtham K, Lewin SR, Emery S, Neaton JD, Brenchley JM, Deeks SG, Sereti I, Douek DC. 2011. Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis 203:780-790. http://dx.doi.org/10.1093/infdis/jiq118.
14. Martin GE, Gouillou M, Hearps AC, Angelovich TA, Cheng AC, Lynch F, Cheng WJ, Paukovics G, Palmer CS, Novak RM, Jaworowski A, Landay AL, Crowe SM. 2013. Age-associated changes in monocyte and innate immune activation markers occur more rapidly in HIV infected women. PLoS One 8:e55279. http://dx.doi.org/10.1371/journal.pone.0055279.
15. Burdo TH, Lo J, Abbara S, Wei J, DeLelys ME, Preffer F, Rosenberg ES, Williams KC, Grinspoon S. 2011. Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients. J Infect Dis 204:1227-1236. http://dx.doi.org/10.1093/infdis/jir520.
16. Burdo TH, Lentz MR, Autissier P, Krishnan A, Halpern E, Letendre S, Rosenberg ES, Ellis RJ, Williams KC. 2011. Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy. J Infect Dis 204:154-163. http://dx.doi.org/10.1093/infdis/jir214.
17. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, Kazzaz Z, Bornstein E, Lambotte O, Altmann D, Blazar BR, Rodriguez B, Teixeira-Johnson L, Landay A, Martin JN, Hecht FM, Picker LJ, Lederman MM, Deeks SG, Douek DC. 2006. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 12:1365-1371. http://dx.doi.org/10.1038/nm1511.
18. Giri MS, Nebozyhn M, Raymond A, Gekonge B, Hancock A, Creer S, Nicols C, Yousef M, Foulkes AS, Mounzer K, Shull J, Silvestri G, Kostman J, Collman RG, Showe L, Montaner LJ. 2009. Circulating monocytes in HIV-1-infected viremic subjects exhibit an antiapoptosis gene signature and virus-and host-mediated apoptosis resistance. J Immunol 182:4459-4470. http://dx.doi.org/10.4049/jimmunol.0801450.
19. Tilton JC, Johnson AJ, Luskin MR, Manion MM, Yang J, Adelsberger JW, Lempicki RA, Hallahan CW, McLaughlin M, Mican JM, Metcalf JA, Iyasere C, Connors M. 2006. Diminished production of monocyte proinflammatory cytokines during human immunodeficiency virus viremia is mediated by type I interferons. J Virol 80:11486-11497. http://dx.doi.org/10.1128/JVI.00324-06.
20. Boasso A, Hardy AW, Landay AL, Martinson JL, Anderson SA, Dolan MJ, Clerici M, Shearer GM. 2008. PDL-1 upregulation on monocytes and T cells by HIV via type I interferon: restricted expression of type I interferon receptor by CCR5-expressing leukocytes. Clin Immunol 129:132-144. http://dx.doi.org/10.1016/j.clim.2008.05.009.
21. Amirayan-Chevillard N, Tissot-Dupont H, Capo C, Brunet C, Dignat-George F, Obadia Y, Gallais H, Mege JL. 2000. Impact of highly active anti-retroviral therapy (HAART) on cytokine production and monocyte subsets in HIV-infected patients. Clin Exp Immunol 120:107-112. http://dx.doi.org/10.1046/j.1365-2249.2000.01201.x.
22. Cozzi-Lepri A, French MA, Baxter J, Okhuysen P, Plana M, Neuhaus J, Landay A. 2011. Resumption of HIV replication is associated with monocyte/macrophage derived cytokine and chemokine changes: results from a large international clinical trial. AIDS 25:1207-1217. http://dx.doi.org/10.1097/QAD.0b013e3283471f10.
23. Zhu T, Muthui D, Holte S, Nickle D, Feng F, Brodie S, Hwangbo Y, Mullins JI, Corey L. 2002. Evidence for human immunodeficiency virus type 1 replication in vivo in CD14+ monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy. J Virol 76:707-716. http://dx.doi.org/10.1128/JVI.76.2.707-716.2002.
24. Lewin SR, Kirihara J, Sonza S, Irving L, Mills J, Crowe SM. 1998. HIV-1 DNA and mRNA concentrations are similar in peripheral blood monocytes and alveolar macrophages in HIV-1-infected individuals. AIDS 12: 719-727. http://dx.doi.org/10.1097/00002030-199807000-00008.
25. Giri MS, Nebozhyn M, Showe L, Montaner LJ. 2006. Microarray data on gene modulation by HIV-1 in immune cells: 2000-2006. J Leukoc Biol 80:1031-1043. http://dx.doi.org/10.1189/jlb.0306157.
26. Rempel H, Calosing C, Sun B, Pulliam L. 2008. Sialoadhesin expressed on IFN-induced monocytes binds HIV-1 and enhances infectivity. PLoS One 3:e1967. http://dx.doi.org/10.1371/journal.pone.0001967.
27. Said EA, Dupuy FP, Trautmann L, Zhang Y, Shi Y, El-Far M, Hill BJ, Noto A, Ancuta P, Peretz Y, Fonseca SG, Van Grevenynghe J, Boulassel MR, Bruneau J, Shoukry NH, Routy J-P, Douek DC, Haddad EK, Sekaly R-P. 2010. Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection. Nat Med 16:452-459. http://dx.doi.org/10.1038/nm.2106.
28. Meier A, Bagchi A, Sidhu HK, Alter G, Suscovich TJ, Kavanagh DG, Streeck H, Brockman MA, LeGall S, Hellman J, Altfeld M. 2008. Upregulation of PD-L1 on monocytes and dendritic cells by HIV-1 derived TLR ligands. AIDS 22:655-658. http://dx.doi.org/10.1097/QAD.0b013e3282f4de23.
29. Zheng L, Yang Y, Guocai L, Pauza CD, Salvato MS. 2007. HIV Tat protein increases Bcl-2 expression in monocytes which inhibits monocyte apoptosis induced by tumor necrosis factor-alpha-related apoptosisinduced ligand. Intervirology 50:224-228. http://dx.doi.org/10.1159/000100565.
30. Laforge M, Campillo-Gimenez L, Monceaux V, Cumont MC, Hurtrel B, Corbeil J, Zaunders J, Elbim C, Estaquier J. 2011. HIV/SIV infection primes monocytes and dendritic cells for apoptosis. PLoS Pathog 7:e1002087. http://dx.doi.org/10.1371/journal.ppat.1002087.
31. Swingler S, Mann AM, Zhou J, Swingler C, Stevenson M. 2007. Apoptotic killing of HIV-1-infected macrophages is subverted by the viral envelope glycoprotein. PLoS Pathog 3:e134. http://dx.doi.org/10.1371/journal.ppat.0030134.
32. Raymond AD, Gekonge B, Giri MS, Hancock A, Papasavvas E, Chehimi J, Kossevkov AV, Nicols C, Yousef M, Mounzer K, Shull J, Kostman J, Showe L, Montaner LJ. 2010. Increased metallothionein gene expression, zinc, and zinc-dependent resistance to apoptosis in circulating monocytes during HIV viremia. J Leukoc Biol 88:589-596. http://dx.doi.org/10.1189/jlb.0110051.
33. Gekonge B, Raymond AD, Yin X, Kostman J, Mounzer K, Collman RG, Showe L, Montaner LJ. 2012. Retinoblastoma protein induction by HIV viremia or CCR5 in monocytes exposed to HIV-1 mediates protection from activation-induced apoptosis: ex vivo and in vitro study. J Leukoc Biol 92:397-405. http://dx.doi.org/10.1189/jlb.1111552.
34. Zhu DM, Shi J, Liu S, Liu Y, Zheng D. 2011. HIV infection enhances TRAIL-induced cell death in macrophage by down-regulating decoy receptor expression and generation of reactive oxygen species. PLoS One 6:e18291. http://dx.doi.org/10.1371/journal.pone.0018291.
35. Alhetheel A, Yakubtsov Y, Abdkader K, Sant N, Diaz-Mitoma F, Kumar A, Kryworuchko M. 2008. Amplification of the signal transducer and activator of transcription I signaling pathway and its association with apoptosis in monocytes from HIV-infected patients. AIDS 22:1137-1144. http://dx.doi.org/10.1097/QAD.0b013e3283013d42.
36. Baruchel S, Wainberg MA. 1992. The role of oxidative stress in disease progression in individuals infected by the human immunodeficiency virus. J Leukoc Biol 52:111-114.
37. Huang Y, Walstrom A, Zhang L, Zhao Y, Cui M, Ye L, Zheng JC. 2009. Type I interferons and interferon regulatory factors regulate TNF-related apoptosis-inducing ligand (TRAIL) in HIV-1-infected macrophages. PLoS One 4:e5397. http://dx.doi.org/10.1371/journal.pone.0005397.
38. Herbeuval JP, Boasso A, Grivel JC, Hardy AW, Anderson SA, Dolan MJ, Chougnet C, Lifson JD, Shearer GM. 2005. TNF-related apoptosisinducing ligand (TRAIL) in HIV-1-infected patients and its in vitro production by antigen-presenting cells. Blood 105:2458-2464. http://dx.doi.org/10.1182/blood-2004-08-3058.
39. Cummins NW, Badley AD. 2010. Mechanisms of HIV-associated lymphocyte apoptosis: 2010. Cell Death Dis 1:e99. http://dx.doi.org/10.1038/cddis.2010.77.
40. Burdo TH, Soulas C, Orzechowski K, Button J, Krishnan A, Sugimoto C, Alvarez X, Kuroda MJ, Williams KC. 2010. Increased monocyte turnover from bone marrow correlates with severity of SIV encephalitis and CD163 levels in plasma. PLoS Pathog 6:e1000842. http://dx.doi.org/10.1371/journal.ppat.1000842.
41. Hasegawa A, Liu H, Ling B, Borda JT, Alvarez X, Sugimoto C, Vinet-Oliphant H, Kim WK, Williams KC, Ribeiro RM, Lackner AA, Veazey RS, Kuroda MJ. 2009. The level of monocyte turnover predicts disease progression in the macaque model of AIDS. Blood 114:2917-2925. http://dx.doi.org/10.1182/blood-2009-02-204263.
42. Li M. 2000. Apoptosis induced by cadmium in human lymphoma U937 cells through Ca2+-calpain and caspase-mitochondria-dependent pathways. J Biol Chem 275:39702-39709. http://dx.doi.org/10.1074/jbc.M007369200.
43. Galán A. 2000. Stimulation of p38 mitogen-activated protein kinase is an early regulatory event for the cadmium-induced apoptosis in human promonocytic cells. J Biol Chem 275:11418-11424. http://dx.doi.org/10.1074/jbc.275.15.11418.
44. Miguel BG, Rodriguez ME, Aller P, Martinez AM, Mata F. 2005. Regulation of cadmium-induced apoptosis by PKC δ in U937 human promonocytic cells. Biochim Biophys Acta 1743:215-222. http://dx.doi.org/10.1016/j.bbamcr.2004.10.011.
45. Sancho P, Fernández C, Yuste VJ, Amrán D, Ramos AM, de Blas E, Susin SA, Aller P. 2006. Regulation of apoptosis/necrosis execution in cadmium-treated human promonocytic cells under different forms of oxidative stress. Apoptosis 11:673-686. http://dx.doi.org/10.1007/s10495-006-5879-3.
46. Kim WK, Sun Y, Do H, Autissier P, Halpern EF, Piatak M, Lifson JD, Burdo TH, McGrath MS, Williams K. 2010. Monocyte heterogeneity underlying phenotypic changes in monocytes according to SIV disease stage. J Leukoc Biol 87:557-567. http://dx.doi.org/10.1189/jlb.0209082.
47. Romero-Sánchez M, Gonzalez-Serna A, Pacheco YM, Ferrando-Martinez S, Machmach K, Garcia-Garcia M, Alvarez-Rios AI, Vidal F, Leal M, Ruiz-Mateos E. 2012. Different biological significance of sCD14 and LPS in HIV-infection: importance of the immunovirology stage and association with HIV-disease progression markers. J Infect 65:431-438. http://dx.doi.org/10.1016/j.jinf.2012.06.008.
48. Walker JA, Sulciner ML, Misgen KD, Miller AD, Burdo TH, Williams K. February 2014. Elevated numbers of CD163+ macrophages in hearts of SIV infected monkeys correlates with cardiac pathology and fibrosis. AIDS Res Hum Retroviruses http://dx.doi.org/10.1089/AID.2013.0268.
49. Haupt Y, Rowan S, Oren M. 1995. p53-mediated apoptosis in HeLa cells can be overcome by excess pRB. Oncogene 10:1563-1571.
50. Shinohara H, Zhou J, Yoshikawa K, Yazumi S, Ko K, Yamaoka Y, Mizukami T, Yoshida T, Akinaga S, Tamaoki T, Motoda H, Benedict WF, Takahashi R. 2000. Retinoblastoma protein-initiated cellular growth arrest overcomes the ability of cotransfected wild-type p53 to induce apoptosis. Br J Cancer 83:1039-1046. http://dx.doi.org/10.1054/bjoc.2000.1411.
51. Youle RJ, Strasser A. 2008. The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 9:47-59. http://dx.doi.org/10.1038/nrm2308.
52. Chipuk JE, Moldoveanu T, Llambi F, Parsons MJ, Green DR. 2010. The BCL-2 family reunion. Mol Cell 37:299-310. http://dx.doi.org/10.1016/j.molcel.2010.01.025.
53. Ola MS, Nawaz M, Ahsan H. 2011. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis. Mol Cell Biochem 351:41-58. http://dx.doi.org/10.1007/s11010-010-0709-x.
54. Jiang X, Wang X. 2004. Cytochrome C-mediated apoptosis. Annu Rev Biochem 73:87-106. http://dx.doi.org/10.1146/annurev.biochem.73.011303.073706.
55. Ow YP, Green DR, Hao Z, Mak TW. 2008. Cytochrome c: functions beyond respiration. Nat Rev Mol Cell Biol 9:532-542. http://dx.doi.org/10.1038/nrm2434.
56. Martensen PM, Justesen J. 2004. Small ISGs coming forward. J Interferon Cytokine Res 24:1-19. http://dx.doi.org/10.1089/107999004772719864.
57. Tahara E, Tahara H, Kanno M, Naka K, Takeda Y, Matsuzaki T, Yamazaki R, Ishihara H, Yasui W, Barrett JC, Ide T, Tahara E. 2005. G1P3, an interferon inducible gene 6-16, is expressed in gastric cancers and inhibits mitochondrial-mediated apoptosis in gastric cancer cell line TMK-1 cell. Cancer Immunol Immunother 54:729-740. http://dx.doi.org/10.1007/s00262-004-0645-2.
58. Cheriyath V, Glaser KB, Waring JF, Baz R, Hussein MA, Borden EC. 2007. G1P3, an IFN-induced survival factor, antagonizes TRAIL-induced apoptosis in human myeloma cells. J Clin Invest 117:3107-3117. http://dx.doi.org/10.1172/JCI31122.
59. Rosebeck S, Leaman DW. 2008. Mitochondrial localization and proapoptotic effects of the interferon-inducible protein ISG12a. Apoptosis 13:562-572. http://dx.doi.org/10.1007/s10495-008-0190-0.
60. Daniel-Carmi V, Makovitzki-Avraham E, Reuven E-M, Goldstein I, Zilkha N, Rotter V, Tzehoval E, Eisenbach L. 2009. The human1-8D gene (IFITM2) is a novel p53 independent pro-apoptotic gene. Int J Cancer 125:2810-2819. http://dx.doi.org/10.1002/ijc.24669.
61. Brass AL, Huang IC, Benita Y, John SP, Krishnan MN, Feeley EM, Ryan BJ, Weyer JL, van der Weyden L, Fikrig E, Adams DJ, Xavier RJ, Farzan M, Elledge SJ. 2009. The IFITM proteins mediate cellular resistance to influenzaAH1N1 virus, West Nile virus, and dengue virus. Cell 139:1243-1254. http://dx.doi.org/10.1016/j.cell.2009.12.017.
62. Cheriyath V, Leaman DW, Borden EC. 2011. Emerging roles of FAM14 family members (G1P3/ISG 6-16 and ISG12/IFI27) in innate immunity and cancer. J Interferon Cytokine Res 31:173-181. http://dx.doi.org/10.1089/jir.2010.0105.
63. Lu J, Pan Q, Rong L, Liu SL, Liang C. 2011. The IFITM proteins inhibit HIV-1 infection. J Virol 85:2126-2137. http://dx.doi.org/10.1128/JVI.01531-10.
64. Malcolm KC, Worthen GS. 2003. Lipopolysaccharide stimulates p38-dependent induction of antiviral genes in neutrophils independently of paracrine factors. J Biol Chem 278:15693-15701. http://dx.doi.org/10.1074/jbc.M212033200.
65. Rustagi A, Gale M, Jr. 2014. Innate antiviral immune signaling, viral evasion and modulation by HIV-1. J Mol Biol 426:1161-1177. http://dx.doi.org/10.1016/j.jmb.2013.12.003.
66. Lederman MM, Calabrese L, Funderburg NT, Clagett B, Medvik K, Bonilla H, Gripshover B, Salata RA, Taege A, Lisgaris M, McComsey GA, Kirchner E, Baum J, Shive C, Asaad R, Kalayjian RC, Sieg SF, Rodriguez B. 2011. Immunologic failure despite suppressive antiretroviral therapy is related to activation and turnover of memory CD4 cells. J Infect Dis 204:1217-1226. http://dx.doi.org/10.1093/infdis/jir507.
67. Bukh AR, Melchjorsen J, Offersen R, Jensen JM, Toft L, Stovring H, Ostergaard L, Tolstrup M, Sogaard OS. 2011. Endotoxemia is associated with altered innate and adaptive immune responses in untreated HIV-1 infected individuals. PLoS One 6:e21275. http://dx.doi.org/10.1371/journal.pone.0021275.
68. Lichtfuss GF, Meehan AC, Cheng WJ, Cameron PU, Lewin SR, Crowe SM, Jaworowski A. 2011. HIV inhibits early signal transduction events triggered by CD16 cross-linking on NK cells, which are important for antibody-dependent cellular cytotoxicity. J Leukoc Biol 89:149-158. http://dx.doi.org/10.1189/jlb.0610371.
69. Tippett E, Cheng WJ, Westhorpe C, Cameron PU, Brew BJ, Lewin SR, Jaworowski A, Crowe SM. 2011. Differential expression of CD163 on monocyte subsets in healthy and HIV-1 infected individuals. PLoS One 6:e19968. http://dx.doi.org/10.1371/journal.pone.0019968.
70. Lichtfuss GF, Cheng WJ, Farsakoglu Y, Paukovics G, Rajasuriar R, Velayudham P, Kramski M, Hearps AC, Cameron PU, Lewin SR, Crowe SM, Jaworowski A. 2012. Virologically suppressed HIV patients show activation of NK cells and persistent innate immune activation. J Immunol 189:1491-1499. http://dx.doi.org/10.4049/jimmunol.1200458.
71. Yan J, Sabbaj S, Bansal A, Amatya N, Shacka JJ, Goepfert PA, Heath SL. 2013. HIV-specific CD8+ T cells from elite controllers are primed for survival. J Virol 87:5170-5181. http://dx.doi.org/10.1128/JVI.02379-12.
72. Dillon SM, Friedlander LJ, Rogers LM, Meditz AL, Folkvord JM, Connick E, McCarter MD, Wilson CC. 2011. Blood myeloid dendritic cells from HIV-1-infected individuals display a proapoptotic profile characterized by decreased Bcl-2 levels and by caspase-3+ frequencies that are associated with levels of plasma viremia and T cell activation in an exploratory study. J Virol 85:397-409. http://dx.doi.org/10.1128/JVI.01118-10.
73. Hearps AC, Angelovich TA, Jaworowski A, Mills J, Landay AL, Crowe SM. 2011. HIV infection and aging of the innate immune system. Sex Health 8:453-464. http://dx.doi.org/10.1071/SH11028.
74. Hearps AC, Martin GE, Angelovich TA, Cheng WJ, Maisa A, Landay AL, Jaworowski A, Crowe SM. 2012. Aging is associated with chronic innate immune activation and dysregulation of monocyte phenotype and function. Aging Cell 11:867-875. http://dx.doi.org/10.1111/j.1474-9726.2012.00851.x.
75. Huang Y, Erdmann N, Peng H, Herek S, Davis JS, Luo X, Ikezu T, Zheng J. 2006. TRAIL-mediated apoptosis in HIV-1-infected macrophages is dependent on the inhibition of Akt-1 phosphorylation. J Immunol 177:2304-2313. http://dx.doi.org/10.4049/jimmunol.177.4.2304.
76. Allers K, Fehr M, Conrad K, Epple HJ, Schurmann D, Geelhaar-Karsch A, Schinnerling K, Moos V, Schneider T. 2014. Macrophages accumulate in the gut mucosa of untreated HIV-infected patients. J Infect Dis 209: 739-748. http://dx.doi.org/10.1093/infdis/jit547.